Tempest Therapeutics Statistics

Total Valuation

TPST has a market cap or net worth of $22.71 million. The enterprise value is $7.80 million.

Market Cap	22.71M
Enterprise Value	7.80M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, after market close.

Earnings Date	May 20, 2025
Ex-Dividend Date	n/a

Share Statistics

TPST has 3.50 million shares outstanding. The number of shares has increased by 80.99% in one year.

Current Share Class	3.50M
Shares Outstanding	3.50M
Shares Change (YoY)	+80.99%
Shares Change (QoQ)	+58.85%
Owned by Insiders (%)	0.19%
Owned by Institutions (%)	6.87%
Float	3.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.15
P/TBV Ratio	1.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.80.

Current Ratio	2.21
Quick Ratio	2.13
Debt / Equity	0.80
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-31.93

Financial Efficiency

Return on equity (ROE) is -182.35% and return on invested capital (ROIC) is -64.13%.

Return on Equity (ROE)	-182.35%
Return on Assets (ROA)	-56.43%
Return on Invested Capital (ROIC)	-64.13%
Return on Capital Employed (ROCE)	-154.12%
Revenue Per Employee	n/a
Profits Per Employee	-$1.74M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.61% in the last 52 weeks. The beta is -2.22, so TPST's price volatility has been lower than the market average.

Beta (5Y)	-2.22
52-Week Price Change	-85.61%
50-Day Moving Average	8.76
200-Day Moving Average	12.95
Relative Strength Index (RSI)	37.49
Average Volume (20 Days)	52,881

Short Selling Information

The latest short interest is 110,022, so 3.14% of the outstanding shares have been sold short.

Short Interest	110,022
Short Previous Month	1.63M
Short % of Shares Out	3.14%
Short % of Float	3.41%
Short Ratio (days to cover)	1.49

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.03M
Pretax Income	-31.75M
Net Income	-41.84M
EBITDA	-41.64M
EBIT	-42.03M
Earnings Per Share (EPS)	-$19.50

Full Income Statement

Balance Sheet

The company has $30.27 million in cash and $15.37 million in debt, giving a net cash position of $14.90 million or $4.26 per share.

Cash & Cash Equivalents	30.27M
Total Debt	15.37M
Net Cash	14.90M
Net Cash Per Share	$4.26
Equity (Book Value)	19.13M
Book Value Per Share	5.65
Working Capital	17.25M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.03 million and capital expenditures -$435,000, giving a free cash flow of -$33.46 million.

Operating Cash Flow	-33.03M
Capital Expenditures	-435,000
Free Cash Flow	-33.46M
FCF Per Share	-$9.56

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-80.99%
Shareholder Yield	n/a
Earnings Yield	-184.28%
FCF Yield	-147.37%

Analyst Forecast

The average price target for TPST is $30.00, which is 362.25% higher than the current price. The consensus rating is "Hold".

Price Target	$30.00
Price Target Difference	362.25%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-24.59%

Stock Forecasts

Stock Splits

The last stock split was on April 9, 2025. It was a reverse split with a ratio of 0.0769231:1.

Last Split Date	Apr 9, 2025
Split Type	Reverse
Split Ratio	0.0769231:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1